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ABSTRACT
Biomedical research  in general simply known as medical research, 
is the basic research, applied research, or translational research 
conducted to aid and support the body of knowledge in the field of 
medicine.  Cancer is a leading cause of death worldwide representing 
13% of all deaths (over 11 million in 2030), breast cancer is the 
most common diagnosed type of cancer among women accounting 
for about 28% of all female cancer cases, while liver cancer is the 
third most common cause of death from cancer worldwide.  
Workers exposed to formaldehyde vapour have been well 
documented to have  an association between formaldehyde 
exposure and several cancers, including nasopharyngeal cancer 
and leukemia. A study was conducted in hatching chicks which 
represented a working environment that was exposed to the 10.9 
ppm formaldehyde vapour, the result illustrated that there were 
pathological changes in the respiratory epithelium. And there was 
also pre-cancerous lesion seen in the epithelium where the normal 
psuedostratified columnar ciliated epithelium was replaced by 
stratified squamous epithelium in the trachea. 
The existing treatment for cancer such as surgery, chemotherapy 
and radiotherapy are not always effective and can cause significant 
side effects. Thus, the author ventured into cancer research via two 
approaches:
In viro therapy, where, Newcastle Disease Virus was used whilst,  in 
herbal therapy where Azadirachta Indica A.Juss (Neem) Extracts, 
Cola Nut (Cola Nitida) Fruit Aqueous Extract and Strobilanthes 
Crispus Extract were used in in-vitro and in-vivo study.  
The oncolytic effect of Newcastle Disease Virus (NDV) strain 
AF2240 was investigated on the MCF-7, MDA-MB-231 breast 
cancer cell lines and 3T3 fibroblast. There were destruction of 
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the cytoskeletal protein, structural and ultrastructural changes, as 
well as molecular changes of the oncogenes which enlightened the 
important biological discoveries of apoptosis in the cancer cells, 
however,  not in the normal cells.
The oncolytic   effect of  Newcastle Disease Virus AF2240 
on Allografted 4T1 Breast Cancer Cells In Balb/c mice 
was well demonstrated and NDV-AF2240 was detected via 
In situ reverse transcriptase polymerase chain reaction (in situ 
RT-PCR), polyclonal chicken antibody and goat anti-chicken 
antibody conjugated with fluorescein isothiocynate (FITC) using 
confocal laser scanning microscopy (CLSM) and negative staining 
transmission electron microscopy (NSTEM). The pre-clinical study 
of this virus is proven  to be safe and effective in animal study, 
however, further study is needed to understand the underlying 
mechanism in making the NDV strain of AF2240 as an anti-cancer 
agent in human.
In herbal theraphy research,  Berberis Vulgaris (L.) Fruit Extract, 
Azadirachta Indica A.Juss (Neem) Extracts, Strobilanthes Crispus 
Extract, and Cola Nut (Cola Nitida) Fruit Aqueous Extract, were 
found to contain high antioxidant and prevent the formation or 
viability of cancer cells. In vitro and in-vivo study showed that they 
have great potential to be developed either into functional food or 
further develop into drugs which can be used  to either treat liver, 
breast and cervical cancers.
Tissue and organ failure, resulting from various forms of  injury such 
as traumatic, metabolic, inflammatory and other diseases normally 
lead to lost of  tissue, organ and system function. To overcome these 
problems,  researchers try to implement tissue engineering as a 
new approach and  to assure the proper re-establishment of organ 
function, the structural and  ultrastructural changes and expression 
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of protein markers during re-modelling of tissue-engineered skin, 
tissue engineered cornea and tissue engineered bone.
In orthopaedics, administration of antibiotics does not provide good 
local bone response due to poor vascularisation of bone tissue; low 
drug penetration and recurrent cases are high due to formation and 
presence of biofilm. The author again takes the lead to develop a 
biocompatible material in-cooperated with antibiotic to overcome 
the problem mentioned above.
As cancer, tissue and organ lost can either be life threatening or 
compensating quality of life, biomedical research play an important 
role to support the medical scenario towards human health and 
wealth creation to the nation. 
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FORMALDEHYDE AND CANCER RISK
Effect of   Formaldehyde Vapour on Respiratory Epithelium 
of   Hatching Chicks
Disinfecting hatching eggs with the use of formaldehyde vapour 
during the last three days of incubation is a common practice 
in commercial hatcheries to minimise the presence of potential 
pathogenic microorganisms and so produce high hatchability and 
healthy chicks. This study was designed to investigate the use 
of scanning electron microscopy (SEM), transmission electron 
microscopy (TEM) and light microscopy (LM), the effects of 
exposure to low levels of formaldehyde vapour (10.9 ppm) on 
the epithelial lining of the respiratory tract of hatching chicks in 
a commercial situation. As a prelude to this study, a control study 
on the development of the respiratory tract was carried out using 
similar techniques and it was established  by the 19th to 20th day of 
incubation, in which the mucociliated cells (Figure 1) of the entire 
respiratory tract of chicks were well developed. 
 Formaldehyde fumigation however, caused destruction to the 
entire respiratory tract of the chicks, inducing pathological changes 
including clumping of cilia and microvilli (Figure 2), development 
of blebs or balloon-like structures on the cilia and microvilli, 
development of blebs or balloon-like structures on the cilial and 
microvillial walls, deciliation and desquamation of the epithelium 
(Figure 3). 
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Figure 1   Caudal trachea. 3-day-old chick. Dense carpet of cilia 
interrupted by  islands of microvillous cells on the mucosal surface. 
X2,750
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Figure 2  Trachea. 1-day –old chick. Extensive clumping of the cilia. 
X2,750
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Figure 3   Caudal trachea. 11-day old chick. Eroded epithelium 
(arrow), note basal cell proliferation (open arrow) from the intact 
epithelial cells. X2,750
 In addition, mucus production was also seen to be affected, 
with increased mucus production and changes in both the nature 
of the mucosubstances and distribution of the mucous cells and 
intraepithelial mucous glands. The morphological changes in the 
lining respiratory tract appeared to last until about the fourth week 
post-hatching, when regeneration of the lining epithelium appeared 
to be completed. The effect of the 10.9 ppm on the respiratory 
epithelium of hatching chicks may also represent the respiratory 
epithelium of the hatchery workers who are also exopsed to the 
formaldehyde. Important note here is a pre-cancerous lesion was 
seen in the epithelium where the normal psuedostratified columnar 
ciliated epithelium was replaced by obvious squamous metaplasia 
in the trachea of a few of the chicken. The lesions found in these 
chicken should be critically reviewed regarding their meaning for 
humans.
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ANTICANCER RESEARCH
Virotheraphy
Cancer is a group of disease characterised by uncontrolled growth 
and spread of abnormal cells. Uncontrolled spreading of the 
abnormal cells eventually will lead to death. Cancer is caused by 
external factors (carcinogenic chemicals, radiation, environment 
and infectious organisms) and internal factors (inherited genetics 
and hormones) (Sainsbury et al., 2000). Despite recent advances 
in treatment, an estimated of 192, 370 new cases of invasive breast 
cancer were expected to occur among women in the US during 
2009; about 1,910 new cases were expected in men (Anonymous, 
2009). In Malaysia, breast cancer is the most commonest cancer 
regardless of ethnicity and age. Existing treatments such as 
chemotherapy and radiotherapy are not always effective and can 
cause significant side effects. With the development of advanced 
biology techniques, viruses of animal origin have been tested for 
virus therapy of human cancers. There has been active interest 
in the potential use of replication-competent oncolytic viruses 
as therapeutic agents in the treatment of cancer (Schirrmacher et 
al.,1998). In the current virus taxonomy Newcastle Disease Virus 
(NDV), or avian paramyxovirus type 1, is classified, with the 
other avian paramyxoviruses,in the genus Avulavirus, subfamily 
Paramyxovirinae, family Paramyxoviridae, order Mononegavirales 
(Dennis et al., 2006; Khadijah and Tan, 2007).
 NDV contains a non segmented single stranded RNA genome 
which coded six proteins including Nucleocapsid Protein (NP), 
Phosphoprotein (P), large protein (L), envelope Matrix protein 
(M), hemaglutinin-neuraminidase (HN), and Fusion protein (F) 
(Figure 4). Generally, NDV is harmless to human. It can cause mild 
flu or conjunctivitis or laryngitis. Innumerable studies have been 
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conducted in several different human tumor cell lines and tumor 
models worldwide (Washburn and Schirrmacher,2002; Phuangsab 
et al.,2001; Csatary et al.,1993; Mallman,1993; Liebrich et al.,1991; 
Bohleet al.,1990; Schild et al.,1988; Cassel and Garret, 1965). The 
NDV possesses several unique properties, it binds specifically to 
tumor cells, it replicates selectively in tumour cell cytoplasm, it is 
relatively safe and it can act as an adjuvant (Schirrmacher et al., 
1998). 
                            (a)                              (b)
Figure 4  a. Schematic representation of the virion structure of NDV.  
Note the carboxy-terminal end of HN and the amino-terminal end of 
F that are exposed on the surface of the virion. b. Negative staining 
electron micrograph of  AF 2240 NDV
 In the present study, a Malaysian local strain of NDV-AF2240 
was tested as an oncolytic agent on 4T1 breast cancer cell allografted 
on Balb/c mice. Although the concept of using viruses as an anti-
cancer agent is still new in Malaysia, recent advances in molecular 
biology and virology enable researchers to manipulate and enhance 
the possibility and the ability of NDV as an oncolytic agent and 
possible future agents in combating breast cancer. Several in vitro 
studies have demonstrated that NDV AF2240 has an oncolytic effect 
towards several types of cancer cells (Fauziah et al., 2002) and 
studies using fluorescent antibody and electron microscopy revealed 
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that AF2240 replicated in the cytoplasm (Zolkapli, 2006). The 
ability of Newcastle disease virus AF2240 to replicate efficiently 
in cancer cells has been demonstrated in both in vivo and in vitro 
(Zolkapli, 2006 and Hadiyatul-Hanim, 2009).  
 Virotherapy holds great promises as a treatment platform for 
cancer. Advantages include the potential lack of cross-resistance 
with standard therapies and their ability to cause tumor destruction 
by numerous mechanisms. However, hurdles such as immune 
response, systemic distribution and intratumoral spread are major 
potential limitations and must be addressed (David et al.,2001). 
Molecular and Cytoskeletal Changes in Breast Cancer Cell 
Lines Treated with Velogenic NDV Strain AF2240
The oncolytic effect of Newcastle Disease Virus (NDV) strain 
AF2240 on the MCF-7, MDA-MB-231 breast cancer cell lines 
and 3T3 fibroblast was carried out to investigate  the cytoskeletal 
protein (Figure 5), NDV structure and the molecular changes of 
the oncogenes. The AF2240 strainwas propagated in 11 days old 
embryonated eggs for 72 hours. The virus in the allantoic fluid was 
harvested, purified and stored at -80°C. The haemagglutination (HA) 
test was conducted on the purified virus to determine the HA titre of 
the NDV strain AF2240 which was 16384 HA units. The inhibition 
concentration of AF2240 towards several types of breast cancer cell 
lines was carried out using microculture tetrazolium (MTT) assay 
via two methods; monolayer and co-culture techniques to determine 
the inhibition concentration (IC50) value. The IC50 values for MDA-
MB-231 breast cancer cell lines treated with NDV strain AF2240 
were 8 and 2 HA units for the monolayer and co-culture techniques 
respectively, whereas the IC50 value for MCF-7 was 2 HA units for 
both techniques. For detection of the virus, polyclonal antibody 
and anti-chicken conjugated with fluorescein isothiocyanate (FITC) 
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were used. The virus particles were detected in the cytoplasm of 
both breast cancer cell lines after 24 and 48 hours post treatment. 
By using independent t-test, the analysis revealed that NDV strain 
AF2240 works better towards MDA-MB-231 cells compared to 
MCF-7 (p ≤0.05). These methods confirmed that NDV causes 
cell death to the breast cancer cells via apoptosis. Moreover, these 
findings also suggested that NDV reacts better towards MDA-
MB-231 cells compared to MCF-7 cell (p ≤ 0.05). 
       
Figure 5  Confocal micrograph of α-tubulin of MCF-7 breast cancer 
cell lines stained with monoclonal anti-α-tubulin conjugated with FITC 
for untreated (A) and treated for 24, 48 and 72 hours (B, C and D) 
respectively. Disruption of α-tubulin (white arrows) was noted after 48 
and 72 hours post treatment (C-D). Magnification: (A-B) 60X, (C-D)  
X 120
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 The study of oncogenes was conducted by using reverse 
transriptase polymerase chain reaction (RT-PCR) method. The 
expressions of c-myc, c-erb-2 and c-fos oncogenes were detected 
at pre and post-treatment in the MCF-7 and MDA-MB-231 
breast cancer cell lines. These results proved that cells which had 
undergone apoptosis due to NDV strain AF2240 treatment did not 
suppress the oncogenes (Figure 6). It can be concluded that even 
though AF2240 NDV strain has significant cytotoxic effect towards 
MCF-7 breast cancer cell lines, the number of apoptotic cells are 
higher in MDA-MB-231 cell line. Therefore, further study is needed 
to understand the underlying mechanism in making the NDV strain 
of AF2240 as an anti-cancer agent. 
                                                               
Figure 6   RT-PCR amplification of c-myc oncogene with 281bps (B) 
and β-actin housekeeping gene with 540bps (A) of breast cancer model 
treated with tamoxifen and separated by gel electrophoresis at week 
1, 2, 3 and 4 (W1, W2, W3 and W4 respectively). The amplification 
of c-myc along with β-actin was detected throughout the experimental 
period
❚❘❘ 14
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Localisation of  (NDV-AF2240) in 4T1 Xenotransplant Breast 
Cancer Balb/c Mice 
In situ reverse transcriptase polymerase chain reaction (in situ 
RT-PCR), polyclonal chicken antibody and goat anti-chicken 
antibody conjugated with fluorescein isothiocynate (FITC) using 
confocal laser scanning microscopy (CLSM) and negative staining 
transmission electron microscopy (NSTEM) were carried out to 
detect the NDV-AF2240 (Figure 7, 8 and 9) in tumor, liver, brain 
and lung during intratumural injection in 4T1 xenotransplant 
breast tumor in female Balb/c mice. Balb/c mice were divided 
into cancerous and non cancerous groups. To localise HN gene 
expression of NDV-AF2240 in tissues, in situ RT-PCR was applied 
on formalin fixed paraffin-embedded (FFPE) sections that were 
positive by negative staining transmission electron microscopy. 
The HN gene expression was detected in all the breast tumor cells. 
However, it was found mainly in the blood vessels of the brain, liver 
and lung. There was no significant difference (p > 0.05) in the HN 
gene intensity of CT/NDV8 and Ct/NDV32 and CT/NDV64 groups. 
In situ RT-PCR showed similar constant strong intensity of β actin 
gene expression in all mentioned tissues. Immunofluoresence and 
CLSM successfully detected the virus particles in tumor and all 
the organs of the cancerous groups during intratumoral injection. 
In tumor tissue, virus were found in the cells, whereas, in the 
lung, brain and liver were found mainly in the blood vessels. 
Negative staining with transmission electron microscopy as a gold 
standard, method was successfully used to detect the NDV-AF2240 
at breast tumor, lung, liver and brain tissues during intratumoral 
injection in 4T1 xenotransplant breast cancer induced in mice. The 
results illustrated the presence of NDV-AF2240 in all organs of 
cancerous groups. The morphology of NDV was seen pleomorphic, 
spherical and ranging from 60-320 nm. The findings showed that 
15 ❘❘❚ 
Fauziah Othman
NDV-AF2240 suppressed the growth of breast cancer and it was 
disseminated in blood vessels of the brain, lung and liver, however, 
found in the cells of the breast cancer. 
       
Figure  7   Apoptotic features of cells treated with NDV
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Figure 8  Replication of NDV in cells. Confocal micrograph of NDV in 
the cytoplasm of MCF-7 cells (arrow)
     
Figure 9  Transmission electron micrograph of NDV-AF2240 isolated 
from the brain of CT/NDV16 group by NSEM. Arrows show the 
filamentous nucleocapsids
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Effect of  Newcastle Disease Virus AF2240 on Allografted 4T1 
Breast Cancer Cells in Balb/c Mice
This study was carried out to investigate the antitumor effect of NDV 
AF2240 in vivo using mouse 4T1 breast cancer cell line. 120 female 
mice were assigned randomly into ten groups; negative control 
(CC), cancer treated with 0.5µg/mL tamoxifen citrate (CT), cancer 
treated with NDV titre 8HA (CNDV8), NDV 16HA (CNDV16), 
NDV 32HA (CNDV32), NDV 64HA (CNDV64), combination 
of NDV 8HA+tamoxifen (CNDV8+T), NDV 64HA+tamoxifen 
(CNDV16+T), NDV 32HA+tamoxifen (CNDV32+T) and NDV 
64HA+tamoxifen (CNDV64+T). 48 mice with tumour growth 
were euthanised weekly to remove tumour samples. At the end 
of the experiment, microscopic examinations were done on the 
cross-sections of tumour samples of these mice. Tumour growth 
was observed in groups; CC, CT, CNDV32+T and CNDB64+T, 
whereas, the rest of the groups had no tumour growth. CND32+T 
and CNDV64+T groups did not show any tumour regression (Figure 
10) having a very low apoptotic index (AI) and a high mitotic index 
(MI) throughout the one month treatment indicating that these 
treatments were not therapeutic. Tamoxifen alone was able to regress 
the tumour but not with a significant difference.
 In groups CNDV32+T and CNDV64+T, there was evidence 
that NDV caused cytoplasmic sequestration of p53 protein from the 
nucleus (Figure 11) to the cytoplasm, indicating the enhancement 
by the virus to induce apoptosis on these cells. The findings of 
this study suggested that NDV titres 8, 16, 32 and 64HA inhibited 
the growth of 4T1 cells, preventing tumour formation. Not all the 
combinations of NDV and tamoxifen were effective, the higher 
NDV titres combined with tamoxifen were neither able to inhibit 
nor regress tumour growth. 
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Figure 10  Clinical signs seen in the treated mice
 In summary, NDV AF2240 alone can inhibit growth of 4T1 
cancer cells and, thus, can be used as a potential oncolytic agent for 
breast cancer treatments. NDV is significantly more effective than 
tamoxifen and can be a very useful alternative anticancer agent for 
breast tumours.
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Figure 11  Light micrographs showing the expression of p53 protein 
representing treatment groups without tumour mass; CNDV8, 
CNDV16, CNDV32, CNDV64, CNDV8+T and CNDV16+T. A: p53 
protein is highly expressed in the cytoplasm of ductal epithelium cell in 
perinuclear fashion. B: Quiescent mammary gland of a normal mouse 
breast tissue also expressing p53 protein (arrow) in the cytoplasm. 
Surrounding the ductal epithelium are fat cells. Mag x20 and 
B is zoomed
 
Newcastle Disease Virus Strain AF2240 on Xenotransplant 
Breast Cancer Cells In  Balb/c Mice and Its Effects on 
Cytokines and Liver Enzymes 
The study was carried out to investigate the effects of very virulent 
Newcastle disease virus (VVNDV) strain AF2240 on Balb/c mice 
induced with 4T1 breast cancer cells. The effects were determined 
by the evaluation of cytokines such as Interleukin-6 (IL-6), 
Interleukin-10 (IL-10), Monocytes Chemo-Attractant Protein 
1(MCP-1),  Tumor Necrosis Factor-alpha (TNF-α), Interferon 
gamma (IFN-γ) and Interleukin-12 (IL-12) in Balb/c mice since 
cytokines can be down regulated or up regulated in the mice 
induced by breast cancer cells. The present study also monitored 
the effects of liver enzymes such as total bilirubin (TBIL), Alanine 
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Aminotransferase (ALT) and Aspartate Aminotransferase (AST) 
in order to confirm that the viruses were safe and inert. All the 
inoculation process of 1X 104 4T1 breast cancer cells to all the 
fifteen (15) target groups were conducted via co-culture technique 
on the first week of the study. The treatment with NDV AF2240 was 
also given on the first day of week one and given daily until the end 
of study at week four. On day one of  week one, blood samples from 
Balb/c mice were collected via cardiac puncture and spleen tissues 
were dissected from the mice were then kept for future analysis. The 
blood samples were processed to get the serum for the analysis of 
Cytometric Bead Array (CBA) with flow cytometer and to conduct 
biochemical tests for liver enzymes. Spleen tissue were processed 
immediately in order to ensure that the lymphocytes in the spleen 
were still fresh during ELISPOT analysis. The results showed that 
from all fifteen groups, there were no significant adverse changes 
in the body weight over time due to the rapid progress of the tumor 
cell. The ANOVA statistical analysis showed the tumor weight 
profile, Cancer Control (CC) and Cancer Tamoxifen (CT) groups 
had a significant heavier tumor weight compared to Normal Control 
(NC) and groups that were treated with VVNDV AF2240. The 
Liver Function Test (LFT) analysis which indicated damage to the 
hepatocytes had shown total bilirubin (TBIL) concentration for CC 
group was significantly different (p ≤ 0.05) compared to the other 
groups especially NC. While for concentration of AST and ALT, 
CC group, Balb/c treated with NDV AF2240 32 HA and Tamoxifen 
(CTNDV32) group and Balb/c treated with NDV AF2240 64 HA 
and Tamoxifen (CTNDV64) group had shown significant difference 
compared to NC group. Two methods were used to observe the 
cytokine elevation secreted in the serum which is through CBA 
method and the ELISPOT method for the cytokine produced by the 
lymphocytes. The studies showed no significant correlation between 
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these two methods, since CBA cannot distinguish whether few 
or more cells had been given the cytokine which can be detected 
separately by the ELISPOT analysis. On the overall, for IL- 6, it 
showed some cytokine elevation between the two methods when 
IL-6 had elevated significantly at CC, CT, Balb/c treated with NDV 
AF2240 32 HA (CNDV32), Balb/c treated with NDV AF2240 
64 HA (CNDV64), Balb/c treated with NDV AF2240 8 HA and 
Tamoxifen (CTNDV8), Balb/c treated with NDV AF2240 16 HA 
and Tamoxifen (CTNDV16) and CTNDV 32 groups. For IFN-γ it 
followed the same trend and groups treated with NDV had high 
expression of IFN-γ compared to CC group, which was believed to 
promote tumor growth. Ironically in this study, IL-10 was observed 
to be up regulated significantly in CTNDV8 until CTNDV64 groups 
compared to untreated groups and groups treated with NDV only. 
While for IL-12 cytokine, in the groups which had been given the 
treatment with NDV as the anti cancer agent, it had shown some 
regulation mechanism to it.  For TNF-α cytokine which can promote 
breast cancer metastasis had shown significant elevation on breast 
cancer groups treated with high titer of NDVs such as CTNDV32 
and CTNDV64. As for MCP-1 cytokine, which is always involved 
in recruiting and migration of inflammatory cells, it also showed 
significant elevation (p ≤ 0.05) and was detected in the groups 
bearing cancer cells and CC group. In conclusion, elevation of pro 
and anti inflammatory cytokine such as IL-6, IL-10, IFN-γ, IL-12, 
TNF-α and MCP-1 had contributed to the progression or regression 
of the tumor.
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Effect of  Velogenic Newcastle Disease Virus Strain AFF2240 
Towards 4T1 Breast Cancer Cell Allografted on Balb/c Mice
The present study was conducted to find a new anti-cancer agent 
for the treatment of breast cancer. The AF-2240 strain of NDV was 
propagated in the allantoic fluid of 11-days-old embryonated eggs 
for 72 hours. The virus was harvested, purified and stored at -800C. 
The haemagglutination (HA) test conducted on the purified virus 
showed that the virus obtained was at 64 HA unit.  The induction 
of breast cancer was done on the auxiliary region of female inbred 
Balb/c mice by using 1 X 104 4T1 breast cancer cells. The treatment 
given and the condition of the animals had no effect in term of 
bodyweight as there was no significant difference noticed between 
tumor bearing mice and tumor-free mice (p>0.05). The effectiveness 
of the treatments was later translated by observing the number of 
apoptotic cells.  All tumor samples exhibited apoptotic features 
analysed by using apoptotic peroxidase staining and comet assay. 
The analysis showed that combination treatments using NDV 
and tamoxifen have no significant effect toward the breast cancer 
cells. Only CT group which were treated with tamoxifen showed 
significant (p<0.05) higher number of apoptotic cells compared to 
the rest of the groups. Like any other types of paramyxovirus, NDV-
AF2240 was found to be localised in the cytoplasm of the breast 
cancer cells observed by using transmission electron microscope. 
Further analysis on the oncogenes (c-myc, c-cerbB2 and c-fos) 
revealed that the presences of the oncogenes in all tumor bearing 
mice group regardless treatment given. In conclusion, NDV-AF2240 
has the potential as an anti-cancer agent if it is used alone or at 
low HA titre if in combination with tamoxifen. The used of the 
virus at high HA titre and in combination with tamoxifen has to be 
monitored with cautious as it has an antagonist effect.
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Herbal Theraphy
From ancient to modern times, herbs and other plants have been 
used as medicinal agents. Rediscovery of the connection between 
plant biotechnology and health is a new generation of botanical 
therapeutics that included plant derivate pharmaceuticals (Raskin 
et al., 2002). In the recent years, there has been growing interest 
in alternative therapies and therapeutic use of natural products, 
especially from plant derivative (Vuito and Snet, 1998) and trend 
towards the use of natural substances which is also believed to 
have potential value as cancer chemo-preventive or therapeutic 
agents. The potential use of higher plants as a source of new drugs 
is still being explored. From the estimated 250,000 – 500,000 
plants species, only 5,000 species have been studied for medicinal 
use (Payne et.al, 1991). Up to 1992, the NCI had only found 3 out 
33,000 plant extracts tested to have anti-tumour activity (Williamson 
et.al, 1996). Traditional medicine is well-known for its nutritional 
value, as well as, its ability to cure various ailments. In recent years 
various constituents have been found to provide protection against 
any disease including cancer (Hakama et.al, 1997; Sporn and Suh, 
2000). Any significant role by dietary intervention is encouraging 
and emerging as an acceptable approach for controlling the cancer 
incidence worldwide (Kellof, 2000).
 Since the beginning of live, plants have played a major role 
in influencing human life. Since a few thousand years ago until 
today, plants ae widely used as food and medicine. To obtain plants 
for medicinal purposes, it is better if only healthy plants are used. 
This is possible by obtaining plants from its natural habitat. The 
constituent of a plant may also change according to the environment 
and seasons. These are important considerations when collecting 
plants. Other factors affecting the medicinal capabilities of a plant 
are: the time when it is picked, season, age of the plant and also 
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its stage in the plant live cycle. These are important medicinal 
considerations to herbs collectors (Muhammad and Mustafa, 1994) 
 In traditional medicine, these ingredients are eaten directly, 
as in the raw form, whereas in modern medicine, the extract is 
reprocessed to obtain the active chemical compound in concentrate 
form (National Research Council, 1992). Plants produce primary 
metabolites and secondary metabolite. Primary metabolite is used 
by the plant itself for its growth and also stored as reserve food. 
Besides that, plants produce secondary metabolites which also 
called secondary compounds. Plant secondary metabolite has potent 
to obtain the needed bioactive chemical. Due to their large biological 
activities, secondary metabolite of plants has been used for century 
in traditional medicine (Hammerschmidt, 2004). Natural product 
is an attractive source of new therapeutic candidate compound of 
sources of new drugs as a tremendous chemical diversity is found 
in millions of species of plants, animals, marine organisms and 
microorganisms (Da Rocha et.al, 2001). 
 About 25% of the drugs prescribed worldwide come from 
plants and 121 active compounds being in current use. Of the 
252 drugs considered as basic and essential by the World Health 
Organization (WHO), 11% are exclusively of plant origin and 
a significant number are synthetic drugs obtained from natural 
precursors (Rates, 2001). Examples of important drugs obtained 
from plants are degoxin from Digitalis spp., quinine and quinidine 
from Chinchona spp., vincristine and vinblastine from Catharanthus 
roseus, atropine from Atropa belladonna and morphine and codeine 
from Papaver somniferum. However, the potential use of higher 
plants as a source of new drugs is still poorly explored. Of the 
estimated 250,000 plants species, only a small percentage has been 
investigated phytochemically and even a smaller percentage has 
been properly studied in terms of the pharmacological properties; 
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in most case, only a pharmacological screening or perliminary 
studies are carried out. It is estimated that 5000 species have been 
studied for the medicinal use (Payne et.al, 1991).
 In the methods to isolate active compound, the plant extracts 
were first qualitatively analysed by thin layer chromatography 
(TLC) and/or other chromatographic methods. Screening should be 
continued to determine the biological activity or to obtain general 
evaluation of biological activities (Figure 12). For purification and 
isolation, the active plant extracts were sequentially fractioned 
(Rates, 2001; Vepoorte, 1989). Each extract or fraction or pure 
compound was subjected to bioassay which can be performed using 
microorganisms, insects, cellular system, cell culture, or in vivo 
(Souza Brito, 1996). 
Figure 12  Methods for Obtaining Active Substance from Plants 
(Rates, 2001)
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 Cancer is the second highest cause of death (12.8%) worldwide 
after cardiovascular disease (29.3%) (WHO, 2004). There were 10.1 
million new cases, 6.2 million deaths and 22 million people living 
with cancer in 2000 (Parkin, 2001). Cancer is the fourth leading 
cause of death in Malaysia, nearly 30 000 cases in each year (Lim, 
2002). Liver cancer is the fifth most important cancer worldwide 
(5.6% incidences), but, because of the very poor prognosis, the 
number of deaths is almost the same as incidence and is the third 
most common cause of death of cancer (Parkin, 2001). Survival 
with liver cancer (HCC) often differed significantly according to the 
tumor stage or size of the tumor (Markovic et al., 1999). Cancer is a 
cellular phenomemnon (Brock &Madigan, 1991). The development 
of cancer cells in many organs and tissues have altered growth 
requirements and continue to grow, piling up to form a small ‘focus 
of growth’ or ‘foci’ (Brock & Madigan, 1991). Hepatic chemical 
carcinogenesis is a multistep process in experimental animals 
(Sarveswaram et al., 2006).
 Carcinogens initiate the process, which is followed by 
regeneration, growth and clonal proliferation, eventually leading to 
cancer. N-Nitrosodiethylamine (DEN) is a representative chemical 
of a family of carcinogenic N-nitroso compounds. Administration 
of DEN to animals has been shown to cause cancer in liver and at 
low incidence in other organs also. Initiation during or after DEN 
exposure is thought to be a rapid metabolism of DEN to ractive 
metabolites that interact with DNA, forming various DNA adducts 
that can lead to mutations. There is extensive evidence that the free 
radicals participate in DEN-induced hepatocarcinogenesis, which 
is confirmed by overexpression of 8-hydroxyguanine in DEN 
administered rat liver. 
 Generally, oxygen free radicals are natural physicological 
products, but also extremely reactive oxygen species, (ROS). They 
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have been proven  to cause numerous cellular anomalies, including 
but not limited to protein damage, deactivation of enzymatic 
activity, alteration of DNA and lipid peroxidation of membranes. 
Continuous interaction of the animal with these free radicals causes 
damage of proteins, lipid, DNA, carbohydrates and membrane, 
resulting in oxidative stress. In order to maintain cellular health, it 
is essential to have a specific and effective chemical scavenger to 
target multiple types of radicals. Most of the commercially based 
antioxidant supplements are single oxidant. It was also observed 
that majority of the antioxidants originate from natural sources. 
 It has been noticed that many of the plants, rich in phenolic 
compunds, are widely used as antioxidant and antimutagenic 
(Sarveswaram et al., 2006). Barbery (Berberis vulgaris L., Var. 
asperma Don., family Berberidaceaae) grows in Asia and Europe. 
Barberry is a well known medicinal plant in Iran and the fruits have 
been used as food (Zargari, 1983; Amin, 1991). Medicinal properties 
for all parts of the plant have been reported, including tonic, 
antimicrobial, antiemetic, antipyretic, antipruritic and cholagogue 
actions, and has been used in some cases like cholecystitis, jaundice, 
dysentery, leishmaniasis, malaria and gallstones (Zargari, 1983; 
Aynehchi, 1986; Nafissi, 1990). In the present investigation, we 
studied the anticarcinogenic effect of B.vulgaris fruit extract (BFE) 
on DEN induced hepatocarcinogenesis in rats. 
Effects of  Berberis Vulgaris (L.) Fruit Extraction on 
Antioxidant Enzyme Activities, α-Fetoprotein Content and 
Histology of   Hepatocarcinogenic Rats
The chemopreventive agent of Berberis vulgaris fruit extract 
in hepatocarcinogenesis female Sprague Dawley rats was 
studied to investigate the possible cancer preventive effect of 
the plant. Total antioxidant activity and phenolic content of BFE 
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extracts were measured. Total phenolic content of BFE in 80% 
methanol was (28000±500 mg/100g), followed by BFE in water 
(10000±400mg/100g). There was an inverse relationship between 
antioxidant activity and phenolic content of Berberis vulgaris 
fruit extract. The severity of neoplasia was studied by histological 
evaluations, body and relative liver weight profile and liver 
tumour marker. Histological evaluations showed loss of normal 
cell organisation when carcinogens were introduced into the body. 
Microscopic observations of the lesion score have shown significant 
difference (p< 0.05) between DEN/AAF and normal control group. 
In liver cancer rats treated with Berberis vulgaris, the activities of 
GST and GGT were significantly lower (p<0.05) compared with 
the DEN/AAF group. The findings showed that BFE could reduce 
the activity of liver enzymes of rats during hepatocarcinogenesis. 
Meanwhile, the RT-PCR analysis of  hepatocytes illustrated the 
AFP gene expression in DEN/AAF group only.
Antioxidant Analysis and In Vitro Anticancer Activities of  
Azadirachta Indica A. Juss (Neem) Extracts
Azadirachta indica, A.Juss (neem) is one of medical plant which 
is found throughout India, Pakistan and Southeast Asia which have 
many wonderous properties. In this study, neuraceutical analysis, 
antioxidant properties, cytotoxic activities and expression of 
causing-cancer genes after exposed to A.indica were carried out. 
Macro and micro mineral content were determined using the atomic 
absorption spectrophotometer (AAS) and energy dispersive X-ray 
microanalysis (EDX). The analysis of antioxidant vitamins A, C and 
E was carried out using high performance liquid chromatography 
(HPLC), where as vitamin C was the highest vitamin content. 
The antioxidant properties of Azadirachta indica was assayed 
by diphenyl-1-picrylhydrazyle (DPPH), β-carotene and total 
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phenolic content. The cytotoxic property was determined using 
the microculture tetrazolium salt (MTT) assay on MCF-7, MDA-
MB-231 breast cancer, cervical cancer (HeLa), Chang Liver, ovarian 
cancer (Caov-3) and normal human breast (MCF-10A) cells. The 
ethanolic extract has the strongest act to inhibit HeLa cells growth 
with IC50 value of 28 µg/mL, followed with IC50 at 50 µg/mL for 
MDA-MB 231 and IC50 at 55 µg/mL for MCF-7 cells. All the solvent 
extractions of Azadirachta indica used exhibited cytotoxic effect 
on hela, cervical cancer, MDA-MB 231 and MCF-7, breast cancer 
cells in range 28 µg/mL-69 µg/mL but not in MCF-10A, Chang liver 
and Caov-3 cells. The study showed that ethanolic extract of neem 
significantly reduce level of c-fos and c-myc expression on HeLa 
cells. Contrary, none of level c-myc, c-erb and c-fos expression was 
reduced by ethanolic extract on MCF-7 and MDA-MB 231 cells. 
This present study revealed that although apoptosis was induced 
(Figure 13), the reducing of the oncogene expression is regulated 
by the type of extract and type of cell lines.  
           
         
Figure 13 Confocal micrograph of treated MCF-7 (A), MDA-MB 2431 
(B) and HeLa cells (C) after exposed to ethanolic extract of A. Indica 
(neem) shows appearance of nucleus fragmentation. Mag 1000x
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Effect of  Strobilanthes Crispus Extract Enzymes Activities 
and Liver Cell during Hepatocarcinogenesis
This study was conducted to determine the effect of aqueous extract of 
Strobilanthes Crispus (SC) with four different doses on experimental 
male albino rats species with induced diethylnitrosamine as initiator 
and 2-acethylaminofluorene as promoter agent. This study was also 
conducted through observing liver cell morphology by using light 
microscope and transmission electron microscope. The exposure 
of animals to carcinogen showed the increased of all specific 
enzymes used. Based on the result it showed that S.crispus may 
inhibit the development of hepatocarcinogenesis before the cells 
undergo to cirrhosis. Transmission electron micrograph showed 
the ultrastructural features of cell such as nucleus, mitochondria 
and rough endoplasmic reticulum (RER). Shrunken nucleus and 
disarrangement of mitochondria and rough endoplasmic reticulum 
(RER) were observed in DEN/AAF induced groups. However, the 
shape of the nucleus and the arrangement of rough endoplasmic 
reticulum (RER) and mitochondria appeared normal in DEN/AAF 
induced rat treated SC group. As a conclusion, this study revealed 
that SC aqueous extract has a potential as an inhibition agent during 
hepatocarcinogenesis without interfering the normal growth of cells. 
Effects of  Cola Nut (Cola Nitida (Vent.) Schott & Endl.) 
Aqueous Extract on Rat Liver during Hepatocarcinogenesis
The use of herbs as medicines has played an important role in 
nearly every culture on earth, including Africa, Asia, Americas 
and the Europe. Herbal therapies are unconventional treatments 
and are widely used for many diseases. Approximately 70 to 90% 
of health care worldwide is delivered by alternative medicine 
(Lewis and Elvin-Lewis, 2003). Among patients with cancer, the 
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use of unconventional medicines, including herbal therapies, has 
been reported to be as low as 5 percent and as high as 60 percent 
(Eisenberg et.al,1993; Risberg et al., 1998). Herbal products are 
taken specifically to prevent diseases or tone down the effects of 
risk for certain diseases. Examples include the consumption of 
green tea and other flavonoid-rich botanicals to take advantage of 
the natural antioxidants in them and the use of garlic  because of the 
rich organosulfur compounds that have been shown, experimentally 
at least, to prevent cancer in animals (Wargovich, 1987; Wargivich 
et al., 1988). 
 Liver cancer is the sixth most common cancer in terms of 
numbers of cases (626,000 or 5.7% of new cancer cases) worldwide, 
but because of the substandard prognosis; the number of deaths is 
almost the same (598,000). Liver cancer is therefore the third most 
common cause of death related to cancer worldwide (Parkin, Bray, 
Ferlay and Pizani, 2005). Liver cancer is the second of deaths due to 
cancer among medically certified deaths in Malaysia (Lim, 2002). 
 It has been estimated that close to about 80-90% of the forms 
of most human cancers are caused by exposure of individuals to 
environmental factors (Figure 14) (Oliveira et al., 2007; Jensen and 
Madsen, 1988). Several agents including viruses, chemicals and 
radiation have been realised to induce cancer in both experimental 
animals and humans (Cooper, 2000).
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Figure  14  Metabolic activation of chemical carcinogens and genotoxic 
and non-genotoxic effects of carcinogens (Oliveira et al., 2007)
Cola nitida is the source of a stimulant and contains methylxanthine 
alkaloids that are also found in coffee, cocoa and tea. The cola nuts 
are used as an herbal medicine worldwide, especially in West Africa; 
partly due to the fact that the cola is a precious commodity (Jayeola, 
2001; Morton, 1992; Trindall, 1997). It has been stated that Cola 
nitida possesses antioxidant activity and other medicinal properties 
(Duke, 2001); as well as its anti-proliferation effect in breast cancer 
cell line (Fontenot, Naragoni, Claville and Gray, 2007). 
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 The effect of Cola nitida aqueous extract in hepatocarcinogenesis 
induced male Sprague Dawley rat livers, and elemental analysis of 
the cola nut were studied to investigate the possible anticancer 
activity. The unprocessed cola nuts were observed for their surface 
morphological structure under the scanning electron microscope 
(SEM). SEM study of cola nut illustrated numerous crystals packed 
in clusters within the cell wall. The elemental analysis results 
revealed that the cola nut contained high amount of oxygen and 
carbon, in addition to potassium, phosphorus and magnesium. 
Potassium, magnesium and phosphorus have been well reported 
as co-factors of antioxidant enzymes to protect the body from 
oxygen free radicals. Additionally, these elements play important 
roles in metabolic mechanisms in the body. Hepatocarcinogenesis 
was induced in rat livers according to the modified Solt and Farber 
method. Diethylnitrosamine (DEN) was injected into the rats at 200 
mg/kg body weight to initiate hepatocarcinogenesis and after two 
weeks this was followed by feeding 0.02% 2-Acetylaminofluorene 
(AAF) to promote the hepatocarcinogenesis. The DEN/AAF 
induced rats were treated with 1, 2.5, and 5% (w/v) concentrations 
of cola nut extract or 0.001, 0.0025, and 0.005% w/v dilutions 
of glycyrrhizin as a drug control. The supplementation of cola 
nut extract decreased the level of plasma and microsomal GGT 
and GST tumor marker enzymes significantly in DENA/AAF 
induced liver tissues even better than glycyrrhizin. Additionally, 
it was revealed that cola nut extract has no effect on the level of 
GST and GGT enzymes in normal cells. The histological and 
ultrastructural examination as well as the lesions scoring results 
demonstrated that the cola nut extract reduced neoplastic stage of 
the hepatocarcinogenenic liver cells more than glycyrrhizin based 
on their abnormal morphology, inflammation, necrosis and fibrosis. 
Moreover, rat’s normal hepatocytes treated with cola nut extract 
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illustrated normal features. These findings suggested that cola nut 
might act as a promising anticancer against hepatocarcinogenesis 
with even higher efficacy compared to glycyrrhizin, without any 
side effects in normal liver cells. 
TISSUE ENGINEERING
Engineered Organs
Tissue and organ failure, resulting from various form of injuries 
either traumatic, metabolic, inflammatory and other disease, 
accounts for about half the total annual expenditure in the world 
health care (Middelkoop et al., 2004). Various treatment modalities 
are employed to overcome the problems which include organ 
transplantation, surgical repair, plastic surgery, artificial prostheses, 
drug theraphy and the use of mechanical devices. However, organ 
and tissue damage cannot be repaired and healed by fibrous 
repair which result in permanent loss of functional tissue. In 
organ transplant, rejection may occur and frequent monitoring is 
needed. The presence of tissue engineering technology provides 
an alternative choice to solve this problem of tissue loss and it has 
been reported to be safe and side effects are minimal (Robert and 
Vacanti, 1993).
 Cell based therapies hold the promise of becoming the major 
therapeutic modalities in the 21st century. A basic understanding of 
cell and developmental biology, bioengineering analysis and design, 
and clinical implementation must be met, in order to implement 
these therapies (Palson and Bhatia, 2004). To overcome these 
problems, researchers try to implement tissue engineering as a 
new approach. Tissue engineering is an interdisciplinary research 
field that grows rapidly, merging the principles of engineering and 
life sciences (Stock and Vacanti, 2001; Vacanti and Langer, 1999). 
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This emerging field is very promising for the future of medicine 
that aims to develop biological substitutes that restore, maintain or 
improve tissue functions. 
 At present, there are increasing numbers of tissue types being 
explored and engineered where stem cell technology was employed. 
Stem cells are used because they are undifferentiated cells which 
are pluripotent in nature and can be induce to differentiate into 
desired cell type. More and more tissue types are being explored 
and engineered. Among other examples of tissue engineered human 
substitutes that are developed includes tissue-engineered bone, 
blood vessels, liver, muscle and nerve conduits (Anon, 2002). 
 Electron microscopy has become a standard tool to assess the 
quality of the fabricated tissue constructs as light microscopy may 
not be able to achieve the resolution obtained by electron microscopy. 
Electron microscopy has been used by many researchers, for 
instance, to assess the biodegradation and bioresorption of calcium 
phosphate ceramics (Damein et al., 1994; LeGeros, 1993), cell 
attachment (Baxter et al., 2002), cell morphology (Trentz et al., 
2003), cell proliferation (Chou et al., 2005), tracing of tissue 
specific proteins (Bianco et al., 1991), calcification of biomaterials 
(Declercq et al., 2005) and bone formation (Hing et al., 1999; Gatti 
et al.,  1990). 
Morphological Changes and Expression of  Protein Markers 
during Remodeling of  Tissue-Engineered Skin
This study was carried out to evaluate the skin remodelling and skin 
development after bilayered fibrin-fibroblast/fibrin-keratinocytes 
skin equivalent (B FF/FK SE) and fibrin without seeded cell (FWC) 
were transplanted into eight weeks old athymic mice. During 
skin modelling, the structural, ultrastructural features and protein 
expression were investigated. Light microscopy revealed that B FF/
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FK SE has good skin remodelling capacity with 6-12 cells thick after 
60 days post-transplantation whereas FWC was only 3-4 cells thick. 
Futher studies were done using the structural features of B FF/FK 
SE and FWC in vitro and in vivo. Scanning electron microscopy 
(SEM) revealed that keratinocytes and fibroblasts in B FF/FK SE 
showed an excellent adherence in fibrin matrix and changes in their 
morphology after 1 to 14 days in vitro (Figure 15).  It ranged from 
rounded to elongated and stellate shape, whereas, for FWC, no cells 
were detected. Transmission electron microscopy (TEM) showed 
that the ultrastructural features during epidermal differentiation and 
regeneration as well as basement membrane formation were well 
developed after B FF/FK SE and FWC transplanted onto athymic 
mice. Confocal microscopy revealed that immunolabellingof 
desmoglein 3 and plakophilin 1 at stratified layer, type IV collagen, 
integrin α6 and type VII collagen at basement membrane zone 
and type I collagen at dermal margin were present after 60 days B 
FF/Fk SE post-transplantation which was similar to native human 
skin (Figure 16). In conclusion, B FF/FK SE showed better skin 
regeneration similar to native human skin and required a shorter 
period of time during wound healing without any contraction.
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Figure 15  Scanning electron micrograph of in vitro of B FF/FK SE 
(A-D). (A) Note, presence of round keratinocytes (arrow), 1300X. (B) 
Note, keratinocytes secreting the extracellular matrix (arrow), 1000X. 
(C) Note, keratinocyte with presence of filopodia which adhere and 
spread over fibrin matrix (m) 7 days post-polymerization (arrow), 
1300X. (D, insert) Increased in the number of keratinocytes 14 days 
post-polymerisation, occasionally with stellate shape keratinocytes 
(arrow), 1000X and 1100X
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Figure 16  Skin basement membrane zone (BMZ) indicating the 
relative location of known BMZ components
   
Structural and Ultrastructural Studies of  Tissue Engineered 
Cornea
Evaluation of corneal organisation and regeneration after 
transplantation of bilayer in vitro cornea construct (BICC) into the 
New Zealand White Strain rabbit’s eye was carried in this study. A 
study was conducted to investigate the structural and ultrastructural 
features after corneal regeneration 90 days post-transplantation. Slit 
lamp microscopic analysis revealed that engineered cornea (EC) 
showed good corneal regeneration with no significant difference 
in cornea transparency to normal cornea (NC). Scanning electron 
microscope (SEM) analysis demonstrated that epithelial surface 
of EC showed significantly similar features to NC compared to 
fibrin cornea (FC) and defect cornea (DC) ( p < 0.05) (Figure 
17). Transmission electron microscope (TEM) analysis showed 
that the basal lamina development of EC was similar to NC 
with the establishment of cell junction compared to FC and DC. 
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Furthermore, the EC showed a compact stromal organisation with 
homogenous collagen fibrils diameter similar to NC (p<0.05). 
However, FC and DC showed a loose  stromal organization with 
heterogenous fibrils diameter, with FC fibrils diameter were bigger 
than that of NC; while for DC, the fibrils diameter was smaller 
than NC (p<0.05). Confocal microscopy analysis confirmed that 
the regenerated epithelial cells in all groups were corneal epithelial 
cells by using corneal differentiation marker, cytokeratin 3 (CK3). 
As a conclusion, the EC demonstrated excellent regenerative ability 
of cornea and better wound healing.
      
Figure  17  Scanning electron micrographs of epithelial thickness 
of central cornea (A-D) at different groups. Normal cornea (A), 
engineered cornea (B), fibrin cornea (C) and defect cornea (D) groups. 
Note, all the group appeared to have differentiated epithelial layer 
laying on top of the basal lamina (arrow). Epi=epithelium, st=stroma. 
X2000
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An electron Microscopic Analysis of  Tricalcium Phosphate 
Hydroxyapatite and Synthetic Hydroxyapatite Bioceramics 
for Bone Tissue Engineering
Tricalcium phosphate hydroxyapatite, TCP/HA (resorbable) 
and synthetic hydroxyapatite, HA (slow-resorbable) scaffold 
biomaterials, both composed of calcium and phosphate in varying 
compositions, were assessed as possible potential scaffold materials 
in bone tissue engineering. The present study used correlative 
light and electron microscopic analysis to investigate the surface 
morphology of human osteoprogenitor cells and its proliferation rate 
in response to alpha medium and differentiation medium at 1 week 
post-culture, effect of fibrin matrix inclusion into scaffold on cells 
and physio-chemical characteristic of the scaffolds (TCP/HA and 
HA) studied in a three-week in vitro model. An in vivo study of a 
three months post-implantation tissue-engineered bone constructs in 
nude mice included the detection of fibroblast and inherent proteins 
of bone tissue, such a s extracellular matrix protein (collagen type 
I) and non-collagenous proteins (osteopontin and bone sialoprotein) 
by scanning electron microscopic immunogold-silver labelling, 
elemental analysis and calcium phosphate elemental mapping 
determined by energy-dispersive X-ray (EDX) microanalysis and 
assessment of bone formation via light and electron microscopy, 
namely scanning electron microscopy (SEM) and transmission 
electron microscopy (TEM). In vivo study, TEM observation 
illustrated new bone formed interdigitally in the micropores of 
TCP/HA and HA grains (Figure 18); however, no bone formation 
was observed at the periphery of the TCP/HA and HA granules as 
revealed by light microscopy. Elemental mapping and structural 
imaging using BSE grey-level and EDX analysis ascertain the similar 
bone formation patterns in the two composites. The expressions of 
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bone matrix proteins, bone sialoprotein and osteopontin and ECM 
deposition, which are predominantly collagen type I as determined 
by SEM immunolabelling clearly verified that the tissue-engineered 
bone constructs possess inherent characterictics of a bone tissue. 
Hence, the correlative microscopy study indicated that TCP/HA is 
much favourable than HA as bone substitute as it promotes new 
bone replacement in places (Figure 19) where degradation can be 
observed and moreover, the bone regeneration rate befitting to the 
resorption rate of the TCP/HA.
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Figure  18  TEM image illustrating (A) the granul shape of TCP/HA 
surrounded by dense collagenous matrix. (Bar: 2µm). (B) An electron-
dense interfacial layer seen at tissue-TCP/HA interface (Bar: 0.5µm). 
(C) Several stratified layers were formed on the TCP/HA substrates. 
The first layer in direct contact of the (1) TCP/HA grain appeared 
electron dense (2),overlying by a moderate dense flocculent material 
(3), followed by amorphous substances with few fibrillar-like strands 
(4) and the outmost layer contained irregular patches of electron dense 
substances (5). (100,000x, bar: 200nm/0.2µm). (D) Maturation of 
osteoid as indicated by condensed collagen matrix and loss of periodic 
banding in collagen fibers due to mineral deposition and extracelllar 
matrix organic components within the fibrils (21,500x, bar: 1µm).
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Figure  19  Vascularisation was observed in the TCP/HA. A) Light 
micrograph.  B) Scanning electron micrograph. C) Secondary scanning 
electron micrograph of blood vesssel. D) Backscattered scanning 
electron micrograph of blood vessel.  Note RBC seen through the blood 
vessel wall
A
B
C D
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ANTIBIOTIC SLOW RELEASE
Biomaterials play an important role in treating diseases and 
improving healthcare. They are commonly used in dental, surgery 
and drug delivery applications. Biomaterials can be used for a 
benign function for example as a heart valve or may be bioactive 
and used for a more interactive purpose such as hydroxyapatite-
coated hip implants.
 Biofilm is the accumulation of adherent microorganism attached 
onto a solid surface by the βexcretion of protective and adhesive 
extracellular polymeric substances (EPS) to form a structured 
community (Costerton et.al, 1999). Biofilms are often characterised 
by surface attachment, structural heterogeneity, genetic diversity, 
complex community interactions and extracellular matrix of 
polymeric substances (Hall-Sttodley et al., 2004).
 Common microorganisms capable of forming biofilm to infect 
prosthetic devices are the gram-positive Staphylococcus aureus and 
gram-negative Pseudomonas aeruginosa (Hatch and Schiller, 1998). 
S.aureus in pasticular is associated with biofilm-related diseases for 
example infectious arthritis, endicarditis and cystic fibrosis (Raad, 
1998). It has the ability to adhere to specofoc host substrate, evade 
host defense, resist antibiotic therapy and is well adapted to the 
human host (Fedtke et al., 2004).
 The delivery of antibiotics in the treatment of bone infection 
at a local site was evaluated in various biodegradable system 
(Schmidt et al.,1995), such as HAP/TCP (hydroxyapatite and 
β-tricalcium phosphate) (Laurent et al.,2008) and GR-HA (glass-
reinforced hydroxyapatite) (Queiroz et al.,2001). Hydroxyapatite 
(HA) is a commonly used biomaterial for medical implants. It is a 
biodegradable polymer with three-dimensional porous polymeric 
matrixes to enhance bone regeneration and facilities cell migration 
and proliferation (Putnam and Mooney, 1996). Hydroxyapatite (HA) 
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is also frequently used in orthopaedic and dental applications owing 
to its biocompatibility, osteoconductivity and bioactivity (Damien 
and Parsons,1991).
 In orthopaedics, parenteral administration of antibiotics does 
not provide good local bone response due to poor vascularisation 
of bone tissue and low drug penetration. Local administration of 
antibiotics would increase drug penetration and also reduce the 
toxicity associated with systemic treatment with antibiotics (Le 
Ray et al., 2005). Furthermore, medical implants remain in close 
contact with biological tissue for prolonged periods and the host 
tissue response should be tested before clinical use. 
Gentamicin-coated Hydroxyapatite in Prevention of  Biofilm 
Formation in Bone Tissue
Biofilm is a multilayered complex microorganism and is typically 
more resistant to the host immune response and routine antibiotic 
therapy. In order to limit biofilm formation, biomaterials loaded 
with suitable antibiotics can be used as a preventive measure. 
Biomaterial hydroxyapatite (HA) is an osteoconductive space 
filler and is produced locally at Malaysia Nuclear Agency. In this 
study, HA coated with the antibiotic gentamicin was explored to 
examine whether it could be reduce or remove biofilm formation. 
To assess IC50 values of gentamicin-coated HA, 108 CFU/ml 
of Staphylococcus aureus (ATCC 12600) and Pseudomonas 
aeruginosa were cultured for 48 hours in a 96-well plate for biofilm 
formation. It was demonstrated that IC50 values of gentamicin-
coated HA were 0.1mg/ml S.aureus and 5mg/ml for P.aeruginosa 
biofilm. Fluorescence staining with acridine orange and propidium 
iodide (AOPI) was also conducted to visualise viability of the 
biofilm. The efficacy of gentamicin-coated HA was also tested in 
vivo. A Teflon catheter was used to create catheter-associated biofilm 
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segments for in vivo implantation. Catheter-associated biofilm was 
examined with scanning electron microscope (SEM) to confirm 
S.aureus biofilm formation (Figure 20). This study showed that 
the gentamicin-coated HA significantly reduced S.aureus bacteria 
count from 14.12 ± 1.09 log10 CFU/ml to 4.61± 0.49 log10 CFU/ml 
(p≤0.05). Therefore, to investigate the structure of biofilm formation 
in vivo post-implantation, tissues immediately surrounding the 
implanted catheter was histologically assessed using haematoxylin 
and eosin (H&E) staining. Thus, this study showed that gentamicin-
coated HA is effective in reducing biofilm viability without causing 
overt toxicity to human osteoblasts in vitro or inflammation when 
implanted in skin. 
       
Figure 20  Scanning electron micrographs of gentamicin-coated HA 
with osteoblasts. (A) The osteoblasts attached onto the HA surface 
coated with 0.1m/ml gentamicin (5000x). (B) The osteoblasts shrinked 
and some cells sloughed off (arrows) from the HA surface coated with 
10.0 mg/ml gentamicin (5000x)
Tobramycin and Gentamicin-Incorporated Calcium 
Phosphate Delivery System in Preventing Biofilm Formation
A biofilm is a thick community of bacteria that is attached to a 
substratum, interface or to each other and embedded in a matrix of 
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extracellular polymeric substances (EPS). In this present study, the 
live event for the development of S. aureus biofilm was viewed under 
live cell imaging system and the morphology of biofilm was viewed 
under scanning electron microscopy (SEM). These microscopic 
studies of S. aureus biofilm are useful for morphological identifiers 
for classifying bacteria biofilms. In order to prevent biofilm infection 
localised to bone and bone tissue (osteomyelitis), calcium phosphate 
was incorporated with either tobramycin or gentamicin to form 2 
types of antibiotic beads. In this study, 3(4, 5-dimethylthiazole-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used 
to assess the efficacy of tobramycin and gentamicin-incorporated 
calcium phosphate against S. aureus biofilm. There was a significant 
different between tobramycin-incorporated calcium phosphate and 
gentamicin-incorporated calcium phosphate on cell viability of S. 
aureus biofilm (p<0.05). Ninhydrin assay was used to investigate the 
elution of tobramycin and gentamicin from the calcium phosphate 
carrier. Gentamicin was released from calcium phosphate higher 
than tobramycin. Tobramycin-incorporated calcium phosphate was 
more cytotoxic on osteoblast than gentamicin-incorporated calcium 
phosphate. Moreover, investigation on the cell morphology and 
cell adherence by using SEM and CLSM showed that seeded cells 
were well attached to the tobramycin and gentamicin-incorporated 
calcium phosphate and continue to grow throughout the 5-days 
period (Figure 21 and Figure 22).  In conclusion, tobramycin and 
gentamicin-incorporated calcium phosphate have the potential 
to be used as a new local drug delivery system in the prevention 
and treatment of bone infections. Furthermore, tobramycin and 
gentamicin-incorporated calcium phosphate scaffold could serve 
as a promising platform for the regeneration of osteoid tissues 
because of their slow release of antibiotic, biocompatibility and 
biodegradability.
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Figure  21  Confocal micrographs of human osteoblasts cultures on 
tobramycin-incorporated calcium phosphate at (A) day 1 , (B) day 3 
and (C) day 5. Note the live osteoblast (green) attached on the surface 
of material (red) (630x)
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Figure 22  Scanning electron micrographs of human osteoblasts 
morphologies on tobramycin-incorporated calcium phosphate. A) 
Spherical cell began to attach on the long plate like-crystals surface 
at day 1 (4,000x). B) Spherical cell found were still  attached to the 
intervene plate like-crystal at day 3 (5,000x). C) Osteoblast found to 
spread with pseudopodia (arrow) at day 5 (7,000x)
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CONCLUSION
A major breakthrough or discovery is a finding or process, often 
preceded by numerous small advances, which lead to a new way of 
thinking about a problem. This new way of thinking is highly useful 
to numerous scientists in addressing problems in diverse fields of 
science. A major breakthrough in biomedical science is a radical 
or new idea, the development of a new methodology, or a new 
instrument or invention. It usually does not occur all at once, but 
involved a process of investigation taking place over a substantial 
period of time and required a great deal of  local knowledge, if 
not both.  High engagement in research activities by enthusiastic 
scientists need to be  facilitated with the practical application 
of scientific discoveries to the development and implementation 
of new ways to prevent, diagnose, and treat disease also known 
as  translational medicine. Before clinical trials in human can 
begin, pre-clinical research have to be conducted during which 
important feasibility, iterative testing and drug safety data are 
collected. Finally, small and large firms in learning how to integrate 
strategic entrepreneurship and collaborative innovation have to be 
well positioned so as they will lead small biomedical research to 
explore bigger horizon before being used commercially towards 
wealth creation.
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PATENTS
TITLE           :   A Drug Delivery System in Bone Tissue 
Filed Year : 2010-03-31
Application No. : PCT/MY2010/000044
Country Filing : PCT
Apllicant : Universiti Putra Malaysia; Malaysian 
Nuklear Agency (Nuklear Malaysia)
ABSTRACT
The hydroxyapatite (HA) biomaterial has been examined for 
its surface morphology. It is irregular shape chips of 2-3 mm. 
However, the pore size is between 150-350µm, which imcluded 
microspores and microspores, while the porosity is between 65-
70%. When placed in contact with viable bone, new bone forms on 
and between the pores of HA. Therefore, the microspores have been 
covered when loaded in gentamycin solution through the images of 
gentamycin-loaded HA under scanning electron microscope (SEM). 
HA was biocompatible with osteoblast by testing with MTT assay. 
There was no significance of IC50 gentamycin at the percentage of 
viability cell was high. In the words, there was significance of IC50 
of gentamycin which was 0.3mg/ml after treatment. The percentage 
of viability of biofilm dropped. The higher concentration of 
gentamycin had been loaded, the lower of viable biofilm percentage. 
Thus, the results indicated that the gentamycin-loaded HA had the 
ability to reduce or eradicate the biofilm formation which formed 
on the implant devices.
Technology : Drug delivery system
Inventor : Fauziah Othman, Asmah Rahmat, Idris 
Besar, Rusnah Mustaffa
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TITLE   :     An Anticancer Agent 
Filed Year : 2009-12-09
Application No. : PCT/MY2009/000204
Country Filing : PCT
Apllicant : Universiti Putra Malaysia
ABSTRACT
The present invention relates to Cola nitida, an anticancer agent, 
the anticancer properties include antioxidant activities: FTC, TBA, 
and DPPH; antioxidant minerals: oxygen, carbon, potassium, 
phosphorus and magnesium; total phenolic and total flavonoid 
content.
Inventor : Fauziah Othman, Asmah Rahmat, Susi 
Endrini, Suherman Jakfa, Wan Nor Izzah 
Wan Mohamad Zain
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